+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Precision Genomic Testing Market Size, Share & Trends Analysis Report by Product & Service (Consumables, Equipment, Services), Application (Oncology, Cardiovascular Diseases), Technology, End-Use, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 110 Pages
  • February 2025
  • Region: Global
  • Grand View Research
  • ID: 5990572
The Precision Genomic Testing Market was valued at USD 15.49 billion in 2024, and is projected to reach USD 35.20 billion by 2030, rising at a CAGR of 14.80%, due to advancements in genomic technologies and an increasing emphasis on personalized medicine. This market encompasses a range of diagnostic tools and techniques used to analyze genetic information, leading to more accurate diagnoses, targeted therapies, and improved patient outcomes. The demand for precision genomic testing is driven by the need for early disease detection, effective treatment planning, and better management of chronic conditions.

Precision genomic testing, driven by CRISPR-Cas9 genome editing technology, is gaining momentum with continuous innovations and increasing investment in research and development. As a result, the market is poised for robust expansion in the coming years. For instance, in March 2024, The Advanced Genomics Collaboration (TAGC) awarded funding to four Innovation Projects led by the University of Melbourne in partnership with entities across the Melbourne Biomedical Precinct. These projects will also benefit from access to cutting-edge DNA sequencing technology at TAGC’s world-class genomics hub, made possible through a collaboration between the University and global biotech firm Illumina, with backing from Invest Victoria.

The rising prevalence of genetic disorders and chronic diseases is driving the demand for precision genomic testing. An estimated 10,000 single-gene diseases result from mutations in a single gene, affecting approximately 10 out of every 1,000 people, according to the World Health Organization. This translates to nearly 70-80 million individuals worldwide living with such conditions. Disorders like cystic fibrosis, Huntington's disease, and various cancers significantly impact on patient health and quality of life. Early and accurate diagnosis is essential for effective treatment and management. Precision genomic testing enables the identification of disease-causing genetic mutations, allowing for timely interventions and personalized treatment plans. As the incidence of these conditions continues to rise, the need for reliable and comprehensive genomic testing solutions will drive market growth.

Additionally, collaborations among academic institutions, research organizations, healthcare providers, and biotechnology companies are accelerating market expansion. These partnerships foster innovation by facilitating knowledge exchange, resource sharing, and technological advancements. Strategic alliances with pharmaceutical firms further integrate precision genomic testing into drug development and personalized medicine. As the collaborative ecosystem grows, the precision genomic testing industry is expected to see sustained growth.

Global Precision Genomic Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the global precision genomic testing market report based on product & service, application, technology, end use, and region:

Product & Service Outlook (Revenue, USD Billion, 2018-2030)

  • Consumables
  • Kits
  • Reagents
  • Equipment
  • Services

Application Outlook (Revenue, USD Billion, 2018-2030)

  • Oncology
  • Cardiovascular Diseases
  • Neurological Disorders
  • Reproductive Health
  • Rare Diseases
  • Others

Technology Outlook (Revenue, USD Billion, 2018-2030)

  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Microarray Technology
  • Sanger Sequencing
  • CRISPR/Cas Systems
  • Others

End Use Outlook (Revenue, USD Billion, 2018-2030)

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research & Academic Institutes
  • Others

Regional Outlook (Revenue, USD Billion, 2018-2030)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product & Service Segment
1.2.2. Application Segment
1.2.3. Technology Segment
1.2.4. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Precision Genomic Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising demand for personalized medicine
3.2.1.2. Advancements in genomic testing technology
3.2.1.3. Increasing government funding & growing focus on genomic studies
3.2.2. Market restraint analysis
3.2.2.1. Ethical and safety concerns related to precision genomic testing technologies
3.3. Precision Genomic Testing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
3.4. Genomic Testing Cost Analysis
3.5. AI Applications in Genomic Testing
Chapter 4. Precision Genomic Testing Market: Product & Service Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Precision Genomic Testing Market Product & Service Movement Analysis
4.3. Global Precision Genomic Testing Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Billion)
4.4. Consumables
4.4.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4.2. Kits
4.4.2.1. Kits market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4.3. Reagents
4.4.3.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5. Equipment
4.5.1. Equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6. Services
4.6.1. Services market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 5. Precision Genomic Testing Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Precision Genomic Testing Market Application Movement Analysis
5.3. Global Precision Genomic Testing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Billion)
5.4. Oncology
5.4.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Billion)
5.5. Cardiovascular Diseases
5.5.1. Cardiovascular diseases market estimates and forecasts, 2018 to 2030 (USD Billion)
5.6. Neurological Disorders
5.6.1. Neurological disorders market estimates and forecasts, 2018 to 2030 (USD Billion)
5.7. Reproductive Health
5.7.1. Reproductive health market estimates and forecasts, 2018 to 2030 (USD Billion)
5.8. Rare Diseases
5.8.1. Rare diseases market estimates and forecasts, 2018 to 2030 (USD Billion)
5.9. Others
5.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 6. Precision Genomic Testing Market: Technology Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Precision Genomic Testing Market Technology Movement Analysis
6.3. Global Precision Genomic Testing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Billion)
6.4. Next-Generation Sequencing
6.4.1. Next-generation sequencing market estimates and forecasts, 2018 to 2030 (USD Billion)
6.5. Polymerase Chain Reaction
6.5.1. Polymerase chain reaction market estimates and forecasts, 2018 to 2030 (USD Billion)
6.6. Microarray Technology
6.6.1. Microarray technology market estimates and forecasts, 2018 to 2030 (USD Billion)
6.7. Sanger Sequencing
6.7.1. Sanger sequencing market estimates and forecasts, 2018 to 2030 (USD Billion)
6.8. CRISPR/Cas Systems
6.8.1. CRISPR/Cas systems market estimates and forecasts, 2018 to 2030 (USD Billion)
6.9. Others
6.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 7. Precision Genomic Testing Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Precision Genomic Testing Market End Use Movement Analysis
7.3. Global Precision Genomic Testing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Billion)
7.4. Hospitals and Clinics
7.4.1. Hospitals and clinics market estimates and forecasts, 2018 to 2030 (USD Billion)
7.5. Diagnostic Laboratories
7.5.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Billion)
7.6. Research & Academic Institutes
7.6.1. Research & academic institutes market estimates and forecasts, 2018 to 2030 (USD Billion)
7.7. Others
7.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 8. Precision Genomic Testing Market: Regional Estimates & Trend Analysis by Product & Service, Application, Technology, and End Use
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
8.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Billion)
8.4.2. U.S.
8.4.2.1. Key country dynamics
8.4.2.2. Competitive scenario
8.4.2.3. Regulatory framework
8.4.2.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Billion)
8.4.3. Canada
8.4.3.1. Key country dynamics
8.4.3.2. Competitive scenario
8.4.3.3. Regulatory framework
8.4.3.4. Canada market estimates and forecasts, 2018 to 2030 (USD Billion)
8.4.4. Mexico
8.4.4.1. Key country dynamics
8.4.4.2. Competitive scenario
8.4.4.3. Regulatory framework
8.4.4.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Billion)
8.5. Europe
8.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Billion)
8.5.2. UK
8.5.2.1. Key country dynamics
8.5.2.2. Competitive scenario
8.5.2.3. Regulatory framework
8.5.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Billion)
8.5.3. Germany
8.5.3.1. Key country dynamics
8.5.3.2. Competitive scenario
8.5.3.3. Regulatory framework
8.5.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Billion)
8.5.4. France
8.5.4.1. Key country dynamics
8.5.4.2. Competitive scenario
8.5.4.3. Regulatory framework
8.5.4.4. France market estimates and forecasts, 2018 to 2030 (USD Billion)
8.5.5. Italy
8.5.5.1. Key country dynamics
8.5.5.2. Competitive scenario
8.5.5.3. Regulatory framework
8.5.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Billion)
8.5.6. Spain
8.5.6.1. Key country dynamics
8.5.6.2. Competitive scenario
8.5.6.3. Regulatory framework
8.5.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Billion)
8.5.7. Denmark
8.5.7.1. Key country dynamics
8.5.7.2. Competitive scenario
8.5.7.3. Denmark market estimates and forecasts, 2018 to 2030 (USD Billion)
8.5.8. Sweden
8.5.8.1. Key country dynamics
8.5.8.2. Competitive scenario
8.5.8.3. Regulatory framework
8.5.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Billion)
8.5.9. Norway
8.5.9.1. Key country dynamics
8.5.9.2. Competitive scenario
8.5.9.3. Regulatory framework
8.5.9.4. Norway market estimates and forecasts, 2018 to 2030 (USD Billion)
8.6. Asia Pacific
8.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Billion)
8.6.2. Japan
8.6.2.1. Key country dynamics
8.6.2.2. Competitive scenario
8.6.2.3. Regulatory framework
8.6.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Billion)
8.6.3. China
8.6.3.1. Key country dynamics
8.6.3.2. Competitive scenario
8.6.3.3. Regulatory framework
8.6.3.4. China market estimates and forecasts, 2018 to 2030 (USD Billion)
8.6.4. India
8.6.4.1. Key country dynamics
8.6.4.2. Competitive scenario
8.6.4.3. Regulatory framework
8.6.4.4. India market estimates and forecasts, 2018 to 2030 (USD Billion)
8.6.5. Australia
8.6.5.1. Key country dynamics
8.6.5.2. Competitive scenario
8.6.5.3. Regulatory framework
8.6.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Billion)
8.6.6. South Korea
8.6.6.1. Key country dynamics
8.6.6.2. Competitive scenario
8.6.6.3. Regulatory framework
8.6.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Billion)
8.6.7. Thailand
8.6.7.1. Key country dynamics
8.6.7.2. Competitive scenario
8.6.7.3. Regulatory framework
8.6.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Billion)
8.7. Latin America
8.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Billion)
8.7.2. Brazil
8.7.2.1. Key country dynamics
8.7.2.2. Competitive scenario
8.7.2.3. Regulatory framework
8.7.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Billion)
8.7.3. Argentina
8.7.3.1. Key country dynamics
8.7.3.2. Competitive scenario
8.7.3.3. Regulatory framework
8.7.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Billion)
8.8. MEA
8.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Billion)
8.8.2. South Africa
8.8.2.1. Key country dynamics
8.8.2.2. Competitive scenario
8.8.2.3. Regulatory framework
8.8.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Billion)
8.8.3. Saudi Arabia
8.8.3.1. Key country dynamics
8.8.3.2. Competitive scenario
8.8.3.3. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Billion)
8.8.4. UAE
8.8.4.1. Key country dynamics
8.8.4.2. Competitive scenario
8.8.4.3. Regulatory framework
8.8.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Billion)
8.8.5. Kuwait
8.8.5.1. Key country dynamics
8.8.5.2. Competitive scenario
8.8.5.3. Regulatory framework
8.8.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Competitive Scenario
9.5. Company Profiles/Listing
9.5.1. Danaher
9.5.1.1. Company overview
9.5.1.2. Financial performance
9.5.1.3. Product & service benchmarking
9.5.1.4. Strategic initiatives
9.5.2. Merck KGaA
9.5.2.1. Company overview
9.5.2.2. Financial performance
9.5.2.3. Product & service benchmarking
9.5.2.4. Strategic initiatives
9.5.3. Revvity, Inc.
9.5.3.1. Company overview
9.5.3.2. Financial performance
9.5.3.3. Product & service benchmarking
9.5.3.4. Strategic initiatives
9.5.4. Maravai LifeSciences
9.5.4.1. Company overview
9.5.4.2. Financial performance
9.5.4.3. Product & service benchmarking
9.5.4.4. Strategic initiatives
9.5.5. GenScript
9.5.5.1. Company overview
9.5.5.2. Financial performance
9.5.5.3. Product & service benchmarking
9.5.5.4. Strategic initiatives
9.5.6. QIAGEN
9.5.6.1. Company overview
9.5.6.2. Financial performance
9.5.6.3. Product & service benchmarking
9.5.6.4. Strategic initiatives
9.5.7. PacBio
9.5.7.1. Company overview
9.5.7.2. Financial performance
9.5.7.3. Product & service benchmarking
9.5.7.4. Strategic initiatives
9.5.8. Oxford Nanopore Technologies plc.
9.5.8.1. Company overview
9.5.8.2. Financial performance
9.5.8.3. Product & service benchmarking
9.5.8.4. Strategic initiatives
9.5.9. Illumina, Inc.
9.5.9.1. Company overview
9.5.9.2. Financial performance
9.5.9.3. Product & service benchmarking
9.5.9.4. Strategic initiatives
9.5.10. 10x Genomics, Inc.
9.5.10.1. Company overview
9.5.10.2. Financial performance
9.5.10.3. Product & service benchmarking
9.5.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global precision genomic testing market, by region, 2018-2030 (USD Billion)
Table 3 Global precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 4 Global precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 5 Global precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 6 Global precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 7 North America precision genomic testing market, by country, 2018-2030 (USD Billion)
Table 8 North America precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 9 North America precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 10 North America precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 11 North America precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 12 U.S. precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 13 U.S. precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 14 U.S. precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 15 U.S. precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 16 Canada precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 17 Canada precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 18 Canada precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 19 Canada precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 20 Mexico precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 21 Mexico precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 22 Mexico precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 23 Mexico precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 24 Europe precision genomic testing market, by country, 2018-2030 (USD Billion)
Table 25 Europe precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 26 Europe precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 27 Europe precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 28 Europe precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 29 UK precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 30 UK precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 31 UK precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 32 UK precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 33 Germany precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 34 Germany precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 35 Germany precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 36 Germany precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 37 France precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 38 France precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 39 France precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 40 France precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 41 Italy precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 42 Italy precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 43 Italy precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 44 Italy precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 45 Spain precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 46 Spain precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 47 Spain precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 48 Spain precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 49 Denmark precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 50 Denmark precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 51 Denmark precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 52 Denmark precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 53 Sweden precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 54 Sweden precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 55 Sweden precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 56 Sweden precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 57 Norway precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 58 Norway precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 59 Norway precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 60 Norway precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 61 Asia Pacific precision genomic testing market, by country, 2018-2030 (USD Billion)
Table 62 Asia Pacific precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 63 Asia Pacific precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 64 Asia Pacific precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 65 Asia Pacific precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 66 Japan precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 67 Japan precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 68 Japan precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 69 Japan precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 70 China precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 71 China precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 72 China precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 73 China precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 74 India precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 75 India precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 76 India precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 77 India precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 78 Australia precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 79 Australia precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 80 Australia precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 81 Australia precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 82 South Korea precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 83 South Korea precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 84 South Korea precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 85 South Korea precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 86 Thailand precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 87 Thailand precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 88 Thailand precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 89 Thailand precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 90 Latin America precision genomic testing market, by country, 2018-2030 (USD Billion)
Table 91 Latin America precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 92 Latin America precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 93 Latin America precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 94 Latin America precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 95 Brazil precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 96 Brazil precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 97 Brazil precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 98 Brazil precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 99 Argentina precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 100 Argentina precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 101 Argentina precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 102 Argentina precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 103 MEA precision genomic testing market, by country, 2018-2030 (USD Billion)
Table 104 MEA precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 105 MEA precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 106 MEA precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 107 MEA precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 108 South Africa precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 109 South Africa precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 110 South Africa precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 111 South Africa precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 112 Saudi Arabia precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 113 Saudi Arabia precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 114 Saudi Arabia precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 115 Saudi Arabia precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 116 UAE precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 117 UAE precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 118 UAE precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 119 UAE precision genomic testing market, by end use, 2018-2030 (USD Billion)
Table 120 Kuwait precision genomic testing market, by product & service, 2018-2030 (USD Billion)
Table 121 Kuwait precision genomic testing market, by application, 2018-2030 (USD Billion)
Table 122 Kuwait precision genomic testing market, by technology, 2018-2030 (USD Billion)
Table 123 Kuwait precision genomic testing market, by end use, 2018-2030 (USD Billion)
List of Figures
Figure 1 Precision genomic testing market segmentation
Figure 2 Data analysis models
Figure 3 Market formulation and validation
Figure 4 Data validating & publishing
Figure 5 Market research process
Figure 6 Information procurement
Figure 7 Primary research
Figure 8 Value-chain-based sizing & forecasting
Figure 9 QFD modelling for market share assessment
Figure 10 Market formulation & validation
Figure 11 Commodity flow analysis
Figure 12 Market outlook
Figure 13 Segment snapshot-1
Figure 14 Segment snapshot-2
Figure 15 Competitive landscape snapshot
Figure 16 Market trends & outlook
Figure 17 Porter’s five force analysis
Figure 18 PESTEL analysis
Figure 19 Precision genomic testing market: Product & service outlook key takeaways
Figure 20 Precision genomic testing market: Product & service movement analysis
Figure 21 Consumables market estimates and forecasts, 2018-2030 (USD billion)
Figure 22 Kits market estimates and forecasts, 2018-2030 (USD billion)
Figure 23 Plasmids market estimates and forecasts, 2018-2030 (USD billion)
Figure 24 Reagents market estimates and forecasts, 2018-2030 (USD billion)
Figure 25 Equipment market estimates and forecasts, 2018-2030 (USD billion)
Figure 26 Services market estimates and forecasts, 2018-2030 (USD billion)
Figure 27 Precision genomic testing market: Application outlook key takeaways
Figure 28 Precision genomic testing market: Application movement analysis
Figure 29 Oncology market estimates and forecasts, 2018-2030 (USD billion)
Figure 30 Cardiovascular diseases market estimates and forecasts, 2018-2030 (USD billion)
Figure 31 Neurological disorders market estimates and forecasts, 2018-2030 (USD billion)
Figure 32 Reproductive health market estimates and forecasts, 2018-2030 (USD billion)
Figure 33 Rare diseases market estimates and forecasts, 2018-2030 (USD billion)
Figure 34 Others market estimates and forecasts, 2018-2030 (USD billion)
Figure 35 Precision genomic testing market: Technology outlook key takeaways
Figure 36 Precision genomic testing market: Technology movement analysis
Figure 37 Next-generation sequencing market estimates and forecasts, 2018-2030 (USD billion)
Figure 38 Polymerase chain reaction market estimates and forecasts, 2018-2030 (USD billion)
Figure 39 Microarray technology market estimates and forecasts, 2018-2030 (USD billion)
Figure 40 Sanger sequencing market estimates and forecasts, 2018-2030 (USD billion)
Figure 41 CRISPR/Cas systems market estimates and forecasts, 2018-2030 (USD billion)
Figure 42 Others market estimates and forecasts, 2018-2030 (USD billion)
Figure 43 Precision genomic testing market: End Use outlook key takeaways
Figure 44 Precision genomic testing market: End Use movement analysis
Figure 45 Hospitals and clinics market estimates and forecasts, 2018-2030 (USD billion)
Figure 46 Diagnostic laboratories market estimates and forecasts, 2018-2030 (USD billion)
Figure 47 Research & academic institutes companies market estimates and forecasts, 2018-2030 (USD billion)
Figure 48 Others market estimates and forecasts, 2018-2030 (USD billion)
Figure 49 Regional marketplace outlook, 2024 & 2030 (USD billion)
Figure 50 Regional marketplace: Key takeaways
Figure 51 North America precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 52 Key country dynamics
Figure 53 U.S. precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 54 Key country dynamics
Figure 55 Canada precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 56 Key country dynamics
Figure 57 Mexico precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 58 Europe precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 59 Key country dynamics
Figure 60 UK precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 61 Key country dynamics
Figure 62 Germany precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 63 Key country dynamics
Figure 64 France precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 65 Key country dynamics
Figure 66 Spain precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 67 Key country dynamics
Figure 68 Italy precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 69 Key country dynamics
Figure 70 Denmark precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 71 Key country dynamics
Figure 72 Sweden precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 73 Key country dynamics
Figure 74 Norway precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 75 Asia Pacific precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 76 Key country dynamics
Figure 77 Japan precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 78 Key country dynamics
Figure 79 China precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 80 Key country dynamics
Figure 81 India precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 82 Key country dynamics
Figure 83 Australia precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 84 Key country dynamics
Figure 85 South Korea precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 86 Key country dynamics
Figure 87 Thailand precision genomic testing market estimates and forecasts, 2018-2030 (USD billion)
Figure 88 Key country dynamics
Figure 89 Market participant categorization
Figure 90 Precision genomic testing market position analysis, 2024
Figure 91 Strategic framework

Companies Mentioned

The major companies profiled in this Precision Genomic Testing market report include:
  • Danaher
  • Merck KGaA
  • Revvity, Inc.
  • Maravai LifeSciences
  • GenScript
  • QIAGEN
  • PacBio
  • Oxford Nanopore Technologies plc.
  • Illumina, Inc.
  • 10x Genomics, Inc.

Methodology

Loading
LOADING...

Table Information